Clinical Trials Map
The results of clinical trials suggest that psychedelics could be used for a range of therapeutic purposes, but figuring out how to participate in psychedelic-assisted therapy as either a therapist or a patient can be complicated. BCSP’s clinical trials map, featuring data from ClinicalTrials.gov, provides a way to navigate past, ongoing and future trials.
Trifecta Research Study
Johns Hopkins Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)
Centre for Addiction and Mental HealthToronto, Ontario, Canada
Psilocybin for Major Depressive Disorder (MDD)
University of Alabama Clinical Research UnitBirmingham, Alabama, United States
Preferred Research Partners-NWA, LLCFayetteville, Arkansas, United States
Preferred Research Partners, Inc.Little Rock, Arkansas, United States
Kadima Neuropsychiatry InstituteLa Jolla, California, United States
West LA VA Medical Center – Mental Health DepartmentLos Angeles, California, United States
Pacific Neuroscience Institute (PNI) at Saint John's Physician PartnersSanta Monica, California, United States
Psychedelic Science InstituteSanta Monica, California, United States
Mountain View Clinical ResearchDenver, Colorado, United States
Connecticut Mental Health Center, Yale UniversityNew Haven, Connecticut, United States
Clinical Neuroscience Solutions Inc.Jacksonville, Florida, United States
Innovative Clinical Research, Inc.Lauderhill, Florida, United States
Clinical Neuroscience Solutions, Inc.Orlando, Florida, United States
Emory UniversityAtlanta, Georgia, United States
CenExel iResearch, LLCDecatur, Georgia, United States
Great Lakes Clinical TrialsChicago, Illinois, United States
Johns Hopkins School of Medicine, Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States
Sunstone Medical PCRockville, Maryland, United States
Washington University School of MedicineSt Louis, Missouri, United States
VA Nebraska Western Iowa Health Care SystemOmaha, Nebraska, United States
Global Medical Institutes, LLC; Princeton Medical InstitutePrinceton, New Jersey, United States
University of New Mexico (UNM) Interdisciplinary Substance Use and Brain Injury (ISUBI) CenterAlbuquerque, New Mexico, United States
NYU Clinical & Translational Science InstituteNew York, New York, United States
Bronx Veterans Research Foundation at the James J. Peters VAMCThe Bronx, New York, United States
AIM Trials, LLCPlano, Texas, United States
Clinical Trials of Texas, LLCSan Antonio, Texas, United States
Cedar Clinical ResearchDraper, Utah, United States
Cedar Clinical Research, Inc.Murray, Utah, United States
Seattle Neuropsychiatric Treatment CenterBellevue, Washington, United States
VA Portland Health Care SystemVancouver, Washington, United States
Microdosing Psychedelics to Improve Mood
Psych ResearchToronto, Ontario, Canada
The ENHANCE Study: taVNS and Psilocybin
University of Wisconsin – MadisonMadison, Wisconsin, United States
A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety
The Ohio State University Department of PsychiatryColumbus, Ohio, United States
Mindfulness-based Psilocybin Therapy for PTSD
The Ohio State University Medical CenterColumbus, Ohio, United States
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
Centre for Addiction and Mental HealthToronto, Ontario, Canada
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
UAB Psychiatry and Behavioral NeurologyBirmingham, Alabama, United States
Lighthouse PsychiatryGilbert, Arizona, United States
Pillar Clinical Research – Little RockLittle Rock, Arkansas, United States
Behavioral Research Specialists, LLCGlendale, California, United States
Sun Valley Research CenterImperial, California, United States
CalNeuro Research GroupLos Angeles, California, United States
Lipov Medical GroupLos Angeles, California, United States
ATP Clinical ResearchOrange, California, United States
NRC Research InstituteOrange, California, United States
Inland Psychiatric Medical Group Inc (IPMG Research)San Juan Capistrano, California, United States
Psychedelic Science InstituteSanta Monica, California, United States
Stanford UniversityStanford, California, United States
Yale School of Medicine – Yale Program for Psychedelic ScienceNew Haven, Connecticut, United States
CNS HealthcareJacksonville, Florida, United States
Accel Research Sites – MaitlandMaitland, Florida, United States
Aqualane Clinical ResearchNaples, Florida, United States
K2 Medical Research TampaTampa, Florida, United States
Emory University Dept of Psychiatry and Behavioral StudiesAtlanta, Georgia, United States
Psych AtlantaMarietta, Georgia, United States
Rush UniversityChicago, Illinois, United States
Tandem Clinical ResearchMarrero, Louisiana, United States
Atlas PsychiatryNew Orleans, Louisiana, United States
Johns Hopkins MedicineBaltimore, Maryland, United States
Sunstone Medical, PCRockville, Maryland, United States
Adams Clinical BostonBoston, Massachusetts, United States
Institute for Integrative TherapiesEden Prairie, Minnesota, United States
The Remedy Mental HealthGolden Valley, Minnesota, United States
Redbird Research, LLCLas Vegas, Nevada, United States
Bio Behavioral HealthToms River, New Jersey, United States
Adams Clinical HarlemNew York, New York, United States
New York State Psychiatric InstituteNew York, New York, United States
Davis Clinical (Adams Clinical Bronx)The Bronx, New York, United States
Adams Clinical WatertownWatertown, New York, United States
SP Research PLLCOklahoma City, Oklahoma, United States
Adams Clinical PhiladelphiaPhiladelphia, Pennsylvania, United States
Flourish Research PhiladelphiaPhiladelphia, Pennsylvania, United States
Austin Clinical Trial PartnersAustin, Texas, United States
Adams Clinical DallasDeSoto, Texas, United States
North Texas Clinical TrialsFort Worth, Texas, United States
Brain Health Consultants and TMS CenterHouston, Texas, United States
Flourish Research San AntonioSan Antonio, Texas, United States
Core Clinical ResearchEverett, Washington, United States
Seattle Neuropsychiatric Treatment CenterSeattle, Washington, United States
Royal Prince Alfred HospitalCamperdown, New South Wales, Australia
Thompson Brain & Mind Healthcare (TBMH)Maroochydore, Queensland, Australia
Ramsay ClinicMelbourne, Victoria, Australia
Neurocentrix ResearchMelbourne, Victoria, Australia
Monash University – Notting HillNotting Hill, Victoria, Australia
Institute of neuropsychiatric Care (INEP)Prague, Czechia
Psyon s.r.o.Prague, Czechia
A-SHINE s.r.o.Předměstí, Czechia
Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des SaarlandesHomburg, Saarland, Germany
Charité Universitaetsmedizin BerlinBerlin, Germany
University Hospital FrankfurtFrankfurt am Main, Germany
Central Institute of Mental HealthMannheim, Germany
Eginitio HospitalAthens, Greece
Attikon University HospitalAthens, Greece
Papageorgiou General HospitalThessaloniki, Greece
Sheaf House – Tallaght Adult Mental Health ServiceDublin, Ireland
La Nua Day Hospital Mental Health CentreGalway, Ireland
Uniwersytecki Szpital Kliniczny W BiałymstokuBialystok, Poland
Promente – Centrum Neurologii i Psychogeriatrii w BydgoszczyBydgoszcz, Poland
UCKGdansk, Poland
Centrum Badan Klinicznych PI-House Sp. z o.oGdansk, Poland
MTZ Clinical Research Powered by PratiaWarsaw, Poland
Department of Pharmacology and Physiology of CNSWarsaw, Poland
Cambridge University Hospital NHSCambridge, United Kingdom
Clerkenwell Health – DoncasterDoncaster, United Kingdom
NHS Research ScotlandEdinburgh, United Kingdom
Queen Elizabeth University HospitalGlasgow, United Kingdom
St Pancras Clinical ResearchLondon, United Kingdom
King's College LondonLondon, United Kingdom
Clerkenwell Health – Welbeck StreetLondon, United Kingdom
Re:Cognition HealthLondon, United Kingdom
Clerkenwell Health – Baker StreetLondon, United Kingdom
Edwardson Building – Campus for Ageing and VitalityNewcastle upon Tyne, United Kingdom
Ascend Clinical ResearchReading, United Kingdom
Sheffield Health and Social Care NHS Foundation TrustSheffield, United Kingdom
Hollins Park Hospital, WinwickWarrington, United Kingdom
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research CenterColumbus, Ohio, United States
Page 1 of 18
How to use the clinical trials map
Clinical trials have provided growing evidence that ketamine, psilocybin, and MDMA can work in combination with therapy to help alleviate a range of mental disorders, including PTSD, depression, substance-use disorders, and anxiety. The field is advancing rapidly, but it can be difficult to navigate changing information to learn more about specific trials.
In the map view, explore clinical trials based on location. Click on a pink cluster or use the + button to zoom in on a particular location. Click on a smaller pink dot to access an overview of a particular clinical trial, including the substance, the phase, and relevant conditions. Click on the “Full Trial Record” link to learn more about the trial on the ClinicalTrials.gov site.
In the list view, the clinical trials tracker offers a tool for researchers and clinicians to quantify and explore trials based on a number of factors. Click on “Filter” to see relevant trials based on substance, trial status, study phase and more. Where the list shows closed trials users are able explore published results, including searching by institution.